Guardant Health $550M Debt Financing with U.S. Bank Trust Company, National Association
Guardant Health completed a private offering of $550 million in 0% Convertible Senior Notes due 2032, which included the full exercise of the initial purchasers' option for an additional $50 million. The notes feature an initial conversion price of approximately $208.95 per share, representing a 35% premium over the November 11, 2026 closing price. Proceeds will be used to repurchase a portion of the company's existing 2027 convertible notes, fund capped call transactions, and for general corporate purposes.
- Value
- $550M
- Counterparty
- U.S. Bank Trust Company, National Association
- Term
- through May 2032